Found 16 matching trials
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
PHASE3The primary objective of the study was to assess the effect of two doses of...
Location
Sanofi-Aventis Investigational Site Number 840041
Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
PHASE2The primary objective of this study was to determine the safety and efficac...
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
PHASE3This is a Phase 3 extension, global, multicenter study to assess the long-t...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham- Site Number : 8400013
A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects
PHASE1This is a Phase 1, randomised, single-blind, placebo-controlled, 2 stage st...
Location
Multiple Locations
Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease
PHASE1The investigators will see if the drug teriflunomide (which is in use in ot...
Location
Dept of Gastroenterology
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
PHASE3The primary objective was to demonstrate the effect of teriflunomide, in co...
Location
Investigational Site Number 840049
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
PHASE2The primary objective was to evaluate the long-term safety and tolerability...
Location
Sanofi-Aventis Administrative Office
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
PHASE2The primary objective was to estimate the tolerability and safety of 2 dose...
Location
Sanofi-Aventis Administrative Office
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
PHASE3The purpose of each study is to independently measure the annualized relaps...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401135
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
PHASE3The primary objective was to determine the effect of teriflunomide on the f...